Provided by Tiger Trade Technology Pte. Ltd.

Precision Biosciences Inc

4.27
+0.06501.55%
Volume:73.35K
Turnover:303.20K
Market Cap:102.67M
PE:-0.51
High:4.29
Open:4.05
Low:4.01
Close:4.20
52wk High:8.82
52wk Low:3.53
Shares:24.07M
Float Shares:22.82M
Volume Ratio:0.59
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3225
EPS(LYR):1.04
ROE:-205.16%
ROA:-45.34%
PB:6.17
PE(LYR):4.10

Loading ...

BRIEF-Precision BioSciences Announces $75 Million Offering Of Common Stock, Pre-Funded Warrants And Warrants

Reuters
·
Nov 11, 2025

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants

THOMSON REUTERS
·
Nov 11, 2025

Precision BioSciences Reports Positive Phase 1 Results for Gene Editing Therapy in Chronic Hepatitis B

Reuters
·
Nov 11, 2025

Precision BioSciences trading halted, news pending

TIPRANKS
·
Nov 11, 2025

Precision BioSciences Q3 revenue falls sharply

Reuters
·
Nov 03, 2025

Precision BioSciences reports third quarter 2025 revenue of less than $0.1 million and research and development expenses of $13.4 million

Reuters
·
Nov 03, 2025

Precision BioSciences Q3 EPS $(1.84) Misses $(1.34) Estimate, Sales $13.000K Miss $5.400M Estimate

Benzinga
·
Nov 03, 2025

BRIEF-Precision BioSciences, Inc. Q3 Revenue USD 13 Thousand

Reuters
·
Nov 03, 2025

Precision BioSciences Inc - Ind Filing for Pbgene-Dmd Expected by End of 2025

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc - Expected Cash Runway Into Second Half of 2027

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences, Inc. Q3 Income From Operations USD -20.667 Million

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc Q3 Shr View $-1.34 -- Lseg Ibes Data

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc expected to post a loss of $1.34 a share - Earnings Preview

Reuters
·
Oct 31, 2025

Press Release: Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025

Dow Jones
·
Oct 31, 2025

H.C. Wainwright Remains a Buy on Precision BioSciences (DTIL)

TIPRANKS
·
Oct 28, 2025

H.C. Wainwright Sticks to Its Buy Rating for Precision BioSciences (DTIL)

TIPRANKS
·
Oct 15, 2025

Precision BioSciences to Present Positive Phase 1 PBGENE-HBV Gene Editing Data at 2025 AASLD Liver Meeting

Reuters
·
Oct 14, 2025

Precision BioSciences Announces Late-Breaking Oral Presentation for Pbgene-Hbv at Aasld the Liver Meeting® 2025

THOMSON REUTERS
·
Oct 14, 2025

Precision BioSciences publishes ARCUS nucleases data

TIPRANKS
·
Oct 09, 2025

Precision BioSciences reveals ARCUS nuclease enables high efficiency gene insertion in dividing and nondividing cells

Reuters
·
Oct 09, 2025